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Abstract
Clostridium botulinum neurotoxin (BoNT) causes flaccid paralysis by disabling synaptic exocytosis. Intoxication requires the
tri-modular protein to undergo conformational changes in response to pH and redox gradients across endosomes, leading
to the formation of a protein-conducting channel. The ,50 kDa light chain (LC) protease is translocated into the cytosol by
the ,100 kDa heavy chain (HC), which consists of two modules: the N-terminal translocation domain (TD) and the C-
terminal Receptor Binding Domain (RBD). Here we exploited the BoNT modular design to identify the minimal requirements
for channel activity and LC translocation in neurons. Using the combined detection of substrate proteolysis and single-
channel currents, we showed that a di-modular protein consisting only of LC and TD was sufficient to translocate active
protease into the cytosol of target cells. The RBD is dispensable for cell entry, channel activity, or LC translocation; however,
it determined a pH threshold for channel formation. These findings indicate that, in addition to its individual functions, each
module acts as a chaperone for the others, working in concert to achieve productive intoxication.
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Introduction
Botulinum neurotoxin (BoNT) inhibits synaptic exocytosis in
peripheral cholinergic synapses causing botulism, a severe disease
characterized by descending flaccid paralysis. Clostridium botulinum
strains express seven BoNT isoforms known as serotypes A to G
[1]. Each BoNT isoform is synthesized as a single polypeptide
chain with a molecular mass of ,150 kDa. The precursor protein
is cleaved either by clostridial or host cell proteases into two
polypeptide chains linked by a disulfide bridge [1–3]. Structurally,
the mature toxin consists of three modules [1,4–6]: a 50 kDa light
chain (LC) Zn
2+-metalloprotease, and the 100 kDa heavy chain
(HC) which encompasses the N-terminal ,50 kDa translocation
domain (TD), also denoted HN and the C-terminal ,50 kDa
receptor-binding domain (RBD) also termed HC.
This tri-modular architecture has a physiological counterpart.
The RBD determines the cellular specificity mediated by the high
affinity interaction with a surface protein receptor, SV2 for
BoNT/A [7,8] and BoNT/E [9], and synaptotagmins I and II for
BoNT/B and BoNT/G [10], and a ganglioside (GT1B) co-
receptor [7,8,10,11]. Then, BoNTs enter sensitive cells via
receptor-mediated endocytosis [1,12,13]. Exposure of the BoNT-
receptor complex to the acidic milieu of endosomes [12–16]
induces a conformational change leading to the insertion of the
HC into the endosomal bilayer membrane, thereby forming
transmembrane channels [17–20].
Previous studies have provided compelling evidence for the
retrieval of a folded LC protease capable of proteolyzing its
SNARE (soluble NSF attachment protein receptor) substrates,
which are essential for synaptic vesicle fusion and neurotransmitter
release [1,2,21,22], only after productive translocation across lipid
bilayer membranes and release from the channel [23]. These
results indicate that the HC of BoNT/A acts as both a channel
and a transmembrane chaperone for the LC to ensure a
translocation competent conformation during LC transit [19,23].
They also support the view that the TD module is the conduit for
the passage of the LC module from the interior of the acidic
endosome into the cytosol allowing access to the intracellular
SNARE substrates [1,13,19,23]. Thus, BoNT represents a
fascinating example of molecular partnership: the HC chaperone
activity driven by a pH gradient across the endosome prevents
aggregation of the LC in the acidic vesicle interior, maintains the
LC unfolded conformation during translocation, and releases the
LC after it refolds at the neutral cytosolic pH. In the process, the
HC channel is occluded by the LC during transit and open after
completion of translocation and release of cargo [23–25].
Here, we investigated the minimal domain requirements for
BoNT channel activity and for productive LC translocation. We
characterized the isolated TD and the TD-disulfide linked to the
catalytic LC using a translocation assay with single molecule
resolution on excised membrane patches of neuroblastoma Neuro
2A cells [24,25]. The system allowed us to dissect the minimal
domain requirements and pH constraints for channel activity and
for LC translocation. We utilized a cell-based neurotoxicity assay
to assess the impact of the single molecule studies at the cellular
level. The RBD was determined to be dispensable for both
channel activity and LC translocation under mild acidic conditions
(pH,6). In contrast, the RBD restricted insertion of the TD into
the membrane until localized to an acidic endosomal compart-
ment where low pH (pH,5) induced channel insertion concurrent
PLoS Pathogens | www.plospathogens.org 1 December 2008 | Volume 4 | Issue 12 | e1000245with partial unfolding of the LC cargo, thereby triggering
productive LC translocation and ultimate release into the cytosolic
compartment.
Materials and Methods
Materials
Unless otherwise specified, all chemicals were purchased from
Sigma-Aldrich. Purified native BoNT/A holotoxin and HC were
from Metabiologics.
Bacterial strains
E. coli strain DH5a cells were used in the cloning procedures
and E. coli strains BL21.DE3.pLysS and BL21.DE3 (RIL) were
used for protein over expression.
Construction of BoNT/A LC-TD
DNA corresponding to the BoNT/A catalytic and translocation
domains was obtained from two separate starting vectors: BoNT/A
LC (unpublished results; a wild-type BoNT/A catalytic domain
sequence) and TD-SDmut [26]; a wild-type BoNT/A TD amino
acid sequence with silent mutations to disrupt an internal Shine
Dalgarno site). The catalytic domain was amplified with primers
that introduced a 59 NdeI site (GGAATTCCATATGCCAT-
TTGTTAATAAAC) and 39 Sac1 site (GGCGAGCTCGCT-
TATTGTATCCTTTATCTAATG) and ligated into a TOPO
vector (Invitrogen, Carlsbad, CA). An internal SacI site was then
removed by QUIK-Change (Stratagene, La Jolla, CA) mutagenesis
using the primer CTCTGGCACACGAACTGATCCACGCTG-
GTC and its reverse complement.
The BoNT/A TD was amplified with primers that introduced a
59 SacI site (GCCGAGCTCTGAACGATCTGTGTATCAAAG-
TTAATAATTGGG) and 39 XhoI site (CCGCTCGAGGTTCT-
TAATATATTCAGTAAATGTAG) and ligated into a TOPO
vector. The catalytic and translocation domains were excised from
the TOPO vectors using NdeI/SacI and SacI/XhoI, respectively
andligatedintoa pET24b vectorthat had been digestedwith NdeI/
XhoI. The use of the engineered SacI site results in the insertion of
an Arg between K447 (cat) and A448 (trans), a feature that was
included inthedesignto improve theefficiencyoftrypsin activation.
Expression and purification of the TD and LC-TD
The BoNT/A TD was expressed and purified from the TD-
SDmut construct as described previously [26] with the following
modification. BoNT/A TD was eluted from the Ni-affinity column
in the presence of 0.2% dodecyl maltoside (DDM) and
concentrated to 0.375 mg/ml in 0.2% DDM, 20 mM Tris,
150 mM NaCl, pH 8.0. The large dilutions used for single
molecule studies insure that the effect of detergent on cell
membranes is negligible. No detergent was required for LC-TD
purification. BoNT/A LC-TD was expressed in E.coli BL21.DE3
(RIL) cells. A 10 ml aliquot was added to one L of Terrific Broth
and induced at an OD=600 nm using 1 mM isopropyl-b-D-
thiogalactopyranoside (IPTG). Cells were harvested after over-
night expression at 18uC and lysed using a French Press. The
protein was purified on a Ni-NTA column followed by a Fast Flow
Q Sepharose column and S200 gel filtration column. Di-chain
BoNT/A LC-TD was generated by cleavage with trypsin: BoNT/
A LC-TD (0.5 mg/ml) was incubated with 1 mg/ml trypsin
overnight at 2262uC. Thereafter, trypsin was inactivated with
0.25 mg/ml trypsin soybean inhibitor for 15 min at 2262uC.
Protein analysis
The purity of all BoNT/A proteins was determined qualitatively
with SDS-PAGE analysis (Figure S1).
Protease activity of BoNT/A proteins
Recombinant SNAP-25 [27,28] was incubated with 60 ng of
BoNT/A holotoxin or LC-TD in 13.2 mM Hepes (pH 7.4),
20 mM dithiothreitol, and 1 mM Zn (CH3COOH)2 for 30 min at
37uC. SDS-PAGE (12%) was used to visualize cleavage of SNAP-
25 by BoNT/A proteins [29] (Figure S2).
Cell culture and patch clamp recordings
Excised patches from Neuro 2A cells in the inside-out
configuration were used as described [24,25]. Current recordings
were obtained under voltage clamp conditions. Records were
acquired at a sampling frequency of 20 kHz and filtered online to
2 kHz with Gaussian filter. All experiments were conducted at
2262uC.
Solutions for patch clamp recordings
To emulate endosomal conditions the trans compartment (bath)
solution contained (in mM) NaCl 200, NaMOPS [3-(N-morpho-
lino) propanesulfonic acid] 5, (pH 7.0 with HCl), tris-(2-carbox-
yethyl) phosphine (TCEP) 0.25, ZnCl2 1, and the cis compartment
(pipet) solution contained (in mM) NaCl 200, NaMES [2-(N-
morpholino) ethanesulfonic acid] 5, (pH 5.3 or pH 6.0 with HCl).
When the cis compartment was tested with pH 7 buffer, the trans
compartment solution set to pH 7.0 was used. The osmolarity of
both solutions was determined to be ,390 mOsm. ZnCl2 was used
to block endogenous channel activity specific to Neuro 2A cells
[30,31]. BoNT protein reconstitution and channel insertion was
achieved by supplementing 2.5–5 mg/ml BoNT holotoxin, HC,
LC-TD, TD, to the pipet solution, which was set to pH 5.3,
pH 6.0 or pH 7.0.
Single-channel data analysis
Analysis was performed on single bursts of each experimental
record. Only single bursts were analyzed due to the random
duration of quiescent periods. A single burst is defined as a set of
openings and closings lasting $50 ms bounded by quiescent
periods of $50 ms before and after. Single-channel conductance
(c) was calculated from Gaussian fits to current amplitude
histograms. The total number of opening events (N) analyzed
was 165,936. Time course of single-channel conductance change
for each experiment was calculated from c of each record, where
t=0 s corresponds to onset of channel activity, and average time
Author Summary
Botulinum neurotoxin, widely acknowledged to be the
most potent toxin known, is a modular nanomachine and
a marvel of protein design. This neurotoxin exploits a
modular design to achieve its potent toxicity, which relies
on one of its modules—the heavy chain channel—to
operate as a specific protein translocating transmembrane
chaperone for another of its component modules—the
light chain protease. Our study shows that a di-modular
protein consisting only of protease and translocation
domains is sufficient to translocate active cargo into the
cytosol of target cells. The receptor binding domain is
dispensable for channel activity or LC translocation;
however, it regulates the pH threshold of channel insertion
into the membrane. The botulinum neurotoxin modular
design embodies a tool for biomolecule delivery to
predetermined target cells.
Domain Requirements for Neurotoxin Translocation
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single condition. The half-time for completion of single-channel
conductance change event (tK) was calculated from Sigmoidal fit
to the average time course. The voltage-dependence of channel
opening was calculated from measurements of the fraction of time
that the channel is open (Po) as a function of voltage by integration
of c histograms where c is 60#c#75 pS. Statistical values
represent means6SEM, unless otherwise indicated. n denotes the
number of different experiments.
Cell-based intoxication assay
Cleavage of endogenous SNAP-25 within Neuro 2A cells
exposed to BoNT/A and truncation proteins was investigated as
described [32]; Neuro-2A cells were seeded at a density of
,120,000 cells per well in a 12-well tissue culture plate in DMEM
culture medium. After incubation for 24 h, the media were
removed and replaced with serum-free media containing 5.0 mgo f
BoNT/A holotoxin, LC-TD or TD. After incubation for ,48 h,
the cells were harvested by removing the media, adding 160 mlo f
16 NuPAGE SDS sample buffer (Invitrogen), and boiling for
10 min.
Western blot analysis
SDS-PAGE and Western blotting were conducted using
standard protocols. Proteins within the whole-cell extract samples
were separated by SDS-PAGE on a 12% Bis-Tris NuPAGE gel in
MOPS/SDS running buffer (Invitrogen) before transfer to a
0.2 mm nitrocellulose membrane for 120 min at 30uC [29]. After
blocking in 2% skim milk/H2O for 20 min at room temperature,
the membrane was washed three times for 5 min at room
temperature with TBST [25 mM Tris (pH 7.4), 137 mM NaCl,
2.7 mM KCl, and 0.1% Tween 20]. Primary antibody, anti-
SNAP-25 mouse monoclonal IgG1 (200 mg/ml; Santa Cruz
Biotechnology, Santa Cruz, CA) diluted 1:1,000 into 2% skim
milk/H2O, was added, and the blot was incubated for 20 min at
room temperature followed by four 5-min washes with TBST at
room temperature. Next, secondary antibody, goat anti-mouse
HRP-conjugated (10 mg/ml; Pierce, Rockford, IL) diluted 1:500
into 2% skim milk/H2O, was added, and the blot was incubated
for 1 h at room temperature followed by washing for 120 min at
room temperature. Bands were visualized with 4 ml of Super-
Signal West Dura Chemiluminescent Substrate (Pierce) and
analyzed with an X-OMAT 2000A processor (Kodak). Western
blot analysis was quantified with the use of Image J software
(NIH).
Results
The channel activity of BoNT/A is confined to the TD
Earlier studies were suggestive of channel forming activity by
the N-terminal half of the HC (HN) [17]. We generated several
truncation constructs of BoNT/A holotoxin, purified them and
examined their channel activity; these include the HC, HN 2 the
N-terminal half of the HC called the translocation domain (TD)
[26], and the LC and TD linked by a disulfide bridge (LC-TD)
[33] (Figure 1). The LC-TD was expressed as a single polypeptide
chain of ,100 kDa with a disulfide bridge; the functionally
relevant di-chain protein was generated by trypsin cleavage of the
linker between the disulfide bridge cysteine residues. Trypsin
nicking did not disrupt the disulfide crosslink, as demonstrated by
SDS PAGE analysis (Figure S1), or affect the enzymatic activity of
the LC (Figure S2).
Channel formation was monitored on excised membrane
patches from neuroblastoma cells under conditions that recapit-
ulate the pH and redox gradients across endosomes: the cis
compartment, defined as the compartment containing BoNT/A
proteins, was held at pH 5.3 and the trans compartment was
maintained at pH 7.0 and supplemented with the membrane
nonpermeable reductant tris-(2-carboxyethyl) phosphine (TCEP).
The LC-TD (Figure 2C), and TD (Figure 2B) exhibited channel
activity with characteristics indistinguishable from those of BoNT/
A HC (Figure 2A): channel activity occurred in bursts of fast
transitions between closed and open states interspersed between
periods of no channel activity; discrete channel openings displayed
a distinctive single-channel conductance (c),65 pS (in symmetric
0.2 M NaCl), with a high probability to reside in the open state
(Po), as illustrated by the records depicted in the corresponding
bottom traces displayed at higher time resolution. The LC-TD
and TD display a voltage dependence similar to the unoccluded
BoNT channel which resulted after completion of LC transloca-
tion [24,25]; V1/2, the voltage at which Po=0.5, 267.262.9 mV
for holotoxin, 259.069.1 mV for LC-TD, and 264.064.2 mV
for TD. Together, these results demonstrate that the channel
activity of BoNT is confined to the TD.
BoNT/A TD forms channels at neutral pH and in the
absence of a transmembrane pH gradient
We previously demonstrated that channel activity for BoNT
HC depends on the presence of a pH gradient (DpH) across the
membrane [23–25]. The HC is a di-modular protein consisting of
the TD and the RBD (Figure 1). Given that the TD forms
channels similar to those of the HC (Figure 2), the question arises
as to whether the RBD modulates the TD channel activity,
particularly with regards to the observed dependence on DpH. As
shown in Figure 3A, the TD channel activity was practically
equivalent when the cis compartment solution was adjusted to
pH 6 or pH 7, thereby reducing (top and middle records) or
eliminating (bottom record) the DpH. Channel activity retained
the hallmark features of the channel measured for the isolated HC
[23,34] and for holotoxin after completion of productive
translocation [24,25] irrespective of DpH, namely, the bursting
pattern of channel activity with an invariant c at ,65 pS
(Figure 3A). The voltage dependence of the Po was modulated by
attenuating or eliminating DpH: The V1/2 was right shifted to
,247 mV when the cis compartment was maintained at pH 6.0
for TD (Figure 3B). The interactions between the TD and the
RBD therefore modulate the pH threshold for membrane
insertion and channel formation; in the absence of the RBD the
TD readily forms channels at neutral pH and in the absence of a
DpH.
BoNT/A LC-TD forms a protein-conducting channel that
translocates LC in a pH-dependent manner
Translocation of BoNT/A LC by the BoNT/A channel can be
monitored in real time and at the single molecule level in excised
membrane patches from neuroblastoma cells [24,25]. LC
translocation through the HC channel requires conditions which
emulate those prevalent across endosomes. Translocation was
observed as a time-dependent increase in Na
+ conductance
through the HC channel recorded at 2100 mV (Figure 4A, top
panel). Initial channel activity exhibited small, discrete events with
c,14 pS (Figure 4A, top, left panel). Progressively, c underwent a
continuous increase until reaching a stable value of 68 pS
(Figure 4A, top, right panel), a constant conductance monitored
for the duration of the experiment (Figure 4C, black circle). This
steady-state c was also the characteristic conductance of isolated
HC recorded under identical conditions [24,25,34]. The half-time
Domain Requirements for Neurotoxin Translocation
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to high conductance, was ,150 s (Figure 4C).
We interpret the intermediate conductance states as reporters of
discrete transient steps during the translocation of the LC across
the membrane; a schematic representation is depicted under the
records shown in Figure 4A, top [24,25]. During protease
translocation, the protein-conducting channel progressively con-
ducts more Na
+ around the polypeptide chain before entering an
exclusively ion-conductive state. For BoNT holotoxin, channel
formation and LC translocation are dependent on DpH; no
channels were detected when the internal solution containing
BoNT was held at pH 6 (Figure 4A, middle trace) or pH 7
(Figure 4A, bottom trace) (Figure 4C, black triangle and black
square), in agreement with our previous findings [23]. In contrast,
LC-TD translocation (Figure 4B, top panel) proceeded even under
a modest DpH (6 on the cis- and 7 on the trans- compartments)
(middle trace). Remarkably, when the excised membrane patches
were bathed in symmetric neutral pH solutions, the LC-TD
formed HC-like channels; low conductance intermediate states
were not detected (Figure 4B, lower panel, and 4C, blue). Circular
dichroism analysis of the LC at pH 7 indicates a high a-helical
content incompatible with a translocation competent conforma-
tion [23]. These results imply that the LC remains folded at pH 7
and therefore cannot go through the ,15 A ˚ diameter of the TD
channel [23,35], thereby allowing expression of the TD channel
activity unperturbed by cargo.
BoNT/A LC-TD cleaves its substrate, SNAP-25, in intact
Neuro 2A cells
The findings shown in Figure 4 imply that, while BoNT/A
holotoxin readily enters neuronal cells via receptor-mediated
endocytosis, the LC-TD devoid of the RBD would insert and be
trapped in the plasma membrane unable to access its cytosolic
substrate SNARE protein. To test this notion, we utilized a cell-
based assay that monitors the amount of intact versus cleaved
endogenous SNAP-25 protein within Neuro-2A cells [32]. This
assay is highly reliable when given a 48 hr exposure to the BoNT
proteins. In the absence of BoNT/A holotoxin or in the presence
of isolated TD [26], SNAP-25 remained intact (Figure 5A, lanes 1
and 8), whereas in the presence of BoNT/A holotoxin, a lower-
molecular-weight proteolysis product of ,24 KDa was detected
(Figure 5A, lane 2). Incubation of cells with LC-TD resulted in
proteolysis of SNAP-25 (Figures 5A and 5B, lanes 3 and 4). The
extent of proteolysis attained by LC-TD was comparable to that
produced by holotoxin, albeit it required higher protein
concentration consistent with a lower efficacy. A single-chain
BoNT/A LC-TD unexposed to trypsin (lane 5) or the LC-TD that
had been trypsin nicked and the disulfide bridge reduced prior to
the assay (lane 6) did not cleave SNAP-25. Remarkably, cleavage
of SNAP-25 by BoNT/A LC-TD does not occur when cells are
preincubated with 2 mM bafilomycin, an inhibitor of the vesicular
proton pump and, therefore, of endosomal acidification [36–38]
(lane 7). These results indicate that BoNT/A LC-TD enters
Figure 1. Modular organization of BoNT/A holotoxin and the different constructs studied. (Top Panel) Schematic representation of BoNT/
A holotoxin showing domain organization; LC denotes light chain, TD, translocation domain, and RBD, receptor binding domain. Numbers indicate
amino acid number from the sequence of BoNT/A and represent the boundaries between individual modules. The disulfide bond between the LC
and the HC in the mature toxin is indicated by 2S-S2. The same convention applies for the proteins represented in the second to seventh panels: the
di-modular heavy chain, HC; the single-chain di-modular light chain-translocation domain, LC-TD; the di-chain di-modular LC-TD; the LC-TD after
nicking and reduction (indicated by 2SH HS2), the isolated, single module translocation domain, TD, and the isolated single module LC. The
structure of BoNT/A holotoxin (PDB accession code 3BTA [4]) and models of the different constructs derived from the holotoxin structure are
displayed adjacent to the corresponding protein. The solvent accessible surfaces were rendered using YASARA (www.yasara.org); the LC is
represented in purple, the TD in orange, and the RBD in red.
doi:10.1371/journal.ppat.1000245.g001
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nicking of the LC cargo from the TD carrier and does not arise
from leaky cells that uptake LC via a non-specific mechanism.
The implication is, therefore, that the inserted LC-TD uses the
constitutive endocytic pathway to enter cells, is subsequently
processed and undergoes translocation of LC with the consequent
cleavage of the intracellular substrate. Together, the results
shown in Figures 4 and 5 provide compelling evidence that the
RBD is not necessary for channel activity or LC translocation,
and that the LC-TD is a di-modular BoNT endowed with the
ability to deliver folded and active LC protease into the cytosol of
target cells.
Discussion
The di-modular LC-TD protein embodies a minimal
design for translocation of active cargo
The tri-modular holotoxin encompassing the LC protease, the
TD and the RBD enters neurons via receptor mediated
endocytosis determined by the RBD module, and achieves the
cytosolic co-localization of the LC protease with its substrate by
the chaperone activity of a TD protein-conducting channel. Here
we demonstrate the BoNT channel-forming entity is confined to
the TD (Figure 2) which, at variance with the holotoxin and the di-
modular HC, displays channel activity irrespective of a trans-
membrane DpH (Figure 3). We further show that for the di-
modular HC the pH threshold for membrane insertion and
channel formation is modulated by the interactions between these
two modules and/or by the RBD interaction with the SV2
receptor (Figure 4A and 4C). Previous studies indicate that
channel formation occurs concomitantly with protein transloca-
tion; therefore we investigated the minimal domain requirements
for productive LC translocation. We established that the di-
modular LC-TD is sufficient for productive translocation of active
protease (Figure 4 and Figure 5) given that the RBD responsible
for cell binding and internalization was unnecessary for BoNT/A
LC translocation (Figure 4B). These results are similar to those
obtained for the translocation of diphtheria toxin catalytic domain
by its translocation domain [39]. The absence of the RBD confers
to the LC-TD a wider pH range for translocation activity
(Figure 4). Having identified this minimal entity, the next set of
questions is what this tells us about the BoNT tri-modular design
in the context of cellular toxicity. The following inferences can be
derived from our analysis.
Figure 2. BoNT/A HC, TD, and LC-TD channel activity measured on excised patches of Neuro 2A cells. Representative single-channel
currents at the indicated voltages; consecutive voltage pulses applied to the same patch for each experimental condition. Channel opening is
indicated by a downward deflection; C and O denote the closed and open states. c values for HC (A)=65.360.4 pS, TD (B)=64.460.4 pS, and LC-TD
(C)=69.260.9 pS. The sections of the recordings obtained at 2110 mV delimited by the black bars are shown in the bottom traces at a 10-fold higher
time resolution; the prototypical square events which are characteristic of unitary channel currents are clearly discerned. An interpretation of the
results is schematically illustrated at the bottom of each panel: The membrane is depicted as a grey bar with magenta boundaries; LC–purple, TD–
orange, RBD–red, and the cysteine involved in the LC-HC disulfide crosslink–green sphere; the SV2 protein-receptor is illustrated in yellow and the
GT1b co-receptor in black (ceramide moiety inserted in the bilayer) and lime (the polar head group); the pH and redox conditions on the cis and trans
compartments are indicated. These conventions also hold for Figure 4.
doi:10.1371/journal.ppat.1000245.g002
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neurotoxicity
The RBD determines targeting of BoNT to the peripheral
nervous system and insures efficient intoxication by at least three
mechanisms. In foodborne botulism, the RBD binds receptors on
the mucosal surface of gut epithelial cells independent of
associated BoNT complex proteins [13,40]. The holotoxin then
undergoes receptor mediated endocytosis and transcytosis with
subsequent delivery to the basolateral side of the epithelial cell
[40–42]. Once released into the circulation, BoNT reaches
cholinergic nerve terminals and a second round of cell entry
occurs. BoNTs enter sensitive neurons via receptor-mediated
endocytosis determined by its high affinity interaction with a
surface protein receptor and a ganglioside co-receptor [1,7,8,10–
13]. During cell binding and intracellular traffic, the RBD restricts
the TD from membrane insertion until its residence within the
acidic interior environment of endosomes. Without the RBD, the
TD readily inserts into the plasma membrane of neuronal cells and
forms channels (Figure 3). For the LC-TD, the LC remains
tethered to its TD carrier on the cell surface by the disulfide
linkage, and folded in the extracellular neutral pH environment.
Accordingly, the RBD serves to chaperone the LC and TD,
insuring that partial unfolding of the LC is concomitant with TD
channel formation thereby promoting productive LC transloca-
tion. A similar example of a toxin RBD-receptor interaction
regulating the pH threshold required for pore formation has been
observed for anthrax toxin [43] and likely reflects intoxication
requirements shared between the two toxins. The lack of structural
similarity between BoNT and anthrax toxin [44], however,
suggests that the mechanisms by which this regulation occurs will
be unique. A LC-RBD di-modular protein has not been
characterized thus far. We conjecture that such an entity would
bind to peripheral neurons and undergo receptor-mediated
endocytosis; however, in the absence of concurrent cargo
translocation, the LC protease would be irreversibly inactivated
by permanent exposure to the acidic endosome interior.
Paradox of LC-TD channel activity versus cellular
specificity
At neutral pH, why does the LC-TD translocate from the
plasma membrane in cell-based neurotoxicity assays but not in the
single molecule studies? To understand this apparent discrepancy,
we first consider the properties of the individual BoNT modules in
the context of neuronal cells. The isolated LC, a globular protein
with a thermolysin-like fold at neutral pH [4,45], does not enter
neurons to cleave its cytosolic substrate [1,23]. Multiple studies
have demonstrated that, upon exposure to acidic pH, the LC
partially unfolds and loses catalytic activity, whereas it remains
folded and enzymatically active at neutral pH [23,46,47]. The LC
requires the TD for access to the cytosol, but the conductance of
TD channels suggests a pore size of #15 A ˚ in diameter
[23,25,34,35]. Therefore, the LC must enter an acidic environ-
ment to translocate into the cytosol. In the absence of RBD, the
TD inserts into the membrane of Neuro 2A cells and would be
open at the negative membrane potentials prevalent at the cell
membrane (Figure 4B). Thus, the TD channel would dissipate the
electrochemical gradients across the plasma membrane, poten-
tially disrupting normal cellular function and activating both the
constitutive and regulated endocytosis pathways to recover cellular
homeostasis. By usurping the endocytotic machinery and entering
acidic endosomes, translocation of the tethered LC could then
proceed [23–25]. Completion of translocation and release of the
LC requires the reduction of the disulfide linkage [23–25].
Consistent with this notion is the finding that cells exposed to
either isolated LC or single chain LC-TD preserve intact their
endogenous SNAP-25 content (Figure 5). Furthermore, and in
accordance with our findings, is the documented ability of LC-TD
to induce paralysis in mice at relatively high protein concentra-
tions [33]. The fact that BoNT/A LC-TD intoxicates neurons in
the absence of the neuronal targeting RBD implies that LC-TD
may be developed into a molecular device with a broad spectrum
of cellular specificity. An initial evaluation of the translocation
activity of LC-TD in a number of non-neuronal cell lines, which
thus far have included CHO (derived from Chinese hamster ovary
cells) and Vero (derived from monkey kidney epithelial cells) cells,
show that these cells do not display translocation activity. The
difference between these cultured epithelial cells and neuronal cells
is likely to be more complex than just the absence of a toxin
receptor and co-receptor, as the endo/exocytotic machinery and
the membrane lipid composition may vary in substantial and
deterministic ways. This issue constitutes a new line of investiga-
tion which may provide unsuspected insights into pathways or
components involved in neuronal trafficking or recycling of
neurotransmitter vesicles.
Figure 3. BoNT/A TD channel activity is independent of a
transmembrane DpH. (A) Top panel illustrates channel activity
monitored with DpH 5 cis/7 trans, middle panel shows DpH 6 cis/7
trans, and bottom panel shows no DpH, 7 cis/7 trans. Representative
single-channel currents recorded at 2100 mV. After GV seal formation,
channel activity begins at 30 min (top), 14 min (middle), and 30 min
(bottom). Low conductance intermediates were not observed. (B)
Analysis of unoccluded channel activity for BoNT/A holotoxin for pH 5/
pH 7 (black circle) (VK=267.262.9 mV), BoNT/A TD for pH 5/pH 7 (red
circle) (VK = 264.064 . 2m V ) , p H6 / p H7 ( m a g e n t a c i r c l e )
(VK=246.863.1 mV), pH 7/pH 7 (blue circle) (VK=255.363.8 mV).
doi:10.1371/journal.ppat.1000245.g003
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The findings presented here highlight the molecular design of
BoNT, a modular machine in which each component functions
individually yet their tight and concerted interplay implies that
each domain serves as a chaperone for the others. The RBD
insures that TD channel formation occurs concurrently with LC
unfolding to a translocation competent conformation (Figure 4B
and 4C). At the positive membrane potential prevailing across
endosomes the TD channel would be closed until it is gated by the
LC to initiate its translocation into the cytosol [34]. The TD itself
protects the LC within the acidic milieu of the endosome interior,
chaperones the LC to the cytosol, and releases the LC in an
Figure 4. BoNT/A holotoxin and LC-TD channel activity in excised patches of Neuro 2A cells over a range of pH values in the cis
compartment. (A and B) Top panels illustrate channel activity monitored with DpH 5 cis/7 trans, middle panels show DpH 6 cis/7 trans, and bottom
panels show DpH, 7 cis/7 trans. (A) BoNT/A holotoxin channel activity elicited under pH 5/pH 7 begins 10 min after GV seal formation, t=0 s, and
transitions from a low conductance intermediate state to the unoccluded state after completion of LC translocation. The vertical lines indicate gapst o
accommodate the full recording in the limited space. A schematic representation is depicted under the records for panels A and B. BoNT/A holotoxin
does not form channels under pH 6/pH 7 or pH 7/pH 7. B, BoNT/A LC-TD channel activity begins 10 min, 12 min, and 45 min after GV seal formation
for pH 5/pH 7, pH 6/pH 7, pH 7/pH 7, respectively. (C) Average time course of conductance change for BoNT/A holotoxin pH 5/pH 7 (black circle) (t1/2
=105620 s), HC pH 5/pH 7(gray square), LC-TD pH 5/pH 7 (red circle) (t1/2=130610 s), LC-TD pH 6/pH 7 (magenta circle) (t1/2=190610 s), and LC-TD
pH 7/pH 7 (blue circle), (3#n#6 per data point; average N per data point=829 events). No channel activity was detected for BoNT/A holotoxin under
pH 6/pH 7 (black triangle) (n=8) and pH 7/pH 7 (black square) (n=8) conditions. (D) Analysis of unoccluded channel activity for BoNT/A holotoxin
pH 5/pH 7 (black circle) (VK=267.262.9 mV), BoNT/A LC-TD for pH 5/pH 7 (red circle) (VK=259.069.1 mV), BoNT/A LC-TD for pH 6/pH 7 (magenta
circle) (VK=228.164.5 mV), BoNT/A LC-TD for pH 7/pH 7 (blue circle) (VK=264.162.9 mV).
doi:10.1371/journal.ppat.1000245.g004
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SNARE proteins [23]. This modular design of BoNT and similar
modular toxins [44] is therefore emerging as a tool for biomolecule
delivery to predetermined target cells [38,48–54]. Model cargo
proteins have been tethered to enzymatically inactive BoNT and
demonstrated to translocate and function within the neuronal cell
[51]. These studies have focused on inactivation or removal of the
enzymatic domain and tethering of additional cargo proteins. By
contrast, replacement of the neuronal targeting RBD with one that
recognizes a distinct, unique cellular surface protein (for reviews
see [2,44,52–54]) could transform BoNT TD into a widespread
delivery system for a diverse array of cargo proteins to the target
tissue of choice, provided cargo proteins reversibly unfold and
refold at the beginning and the end of translocation thereby
retaining a tight association with the protein-conducting channel
throughout the process.
Supporting Information
Figure S1 Coomassie blue stained SDS-PAGE analysis of
BoNT/A holotoxin, LC-TD, and TD; numbers denote Mr
Standards in kDa; DTT (+)( 2) indicate presence or absence of
100 mM dithiothreitol in the sample loading buffer.
Found at: doi:10.1371/journal.ppat.1000245.s001 (1.23 MB PDF)
Figure S2 Coomassie blue stained SDS-PAGE analysis of in vitro
cleavage of SNAP-25 by BoNT/A holotoxin and LC-TD. Lane 1
shows SNAP-25 in the absence of BoNT/A - control; lane 2, a
21 kDa molecular weight standard protein; lanes 3 and 4 show
SNAP-25 cleaved by BoNT/A holotoxin and by LC-TD. Both
BoNT/A holotoxin and LC-TD cleaved SNAP-25 to completion
as compared to the uncleaved control presented in lane 1.
Found at: doi:10.1371/journal.ppat.1000245.s002 (1.32 MB PDF)
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